Conclusion A multidrug resistance cell line (SPC-A-1/CDDP) from human lung adenocarcinoma is established.It can be used to downstream experiment.

• 结论本研究建立了稳定的人肺腺癌多药耐药细胞系（SPC-A-1/CDDP），可应用于下游实验。